• About Hair Loss
  • Stemson Solution
    • Stemson Solution
    • Hair Follicle Biology
  • Company
    • Stemson Background
    • Team
    • Contact
  • Careers
  • News
Logo
  • About Hair Loss
  • Stemson Solution
    • Stemson Solution
    • Hair Follicle Biology
Logo
  • Company
    • Stemson Background
    • Team
    • Contact
  • Careers
  • News

Cell therapy pioneer Kevin D’Amour, PhD, joins Stemson as Chief Scientific Officer


February 1, 2023

Stemson Therapeutics announced today that Kevin D’Amour has joined the company as Chief Scientific Officer.  Kevin has 20 years of experience in cell therapy development, and spent ten years as Chief Scientific Officer at ViaCyte.  While at Viacyte, Kevin took three stem cell-derived cell therapy products into the clinic to treat Type 1 Diabetes.

See the press release

< Back to News
Logo

© 2023 Stemson Therapeutics Corporation. All rights reserved.

  • LEARN MORE
    • About Hair Loss
    • Stemson Solution
    • Hair Follicle Biology
  • ABOUT US
    • Stemson Background
    • Team
    • News
    • Careers
  • SUPPORT
    • Contact
    • Privacy Policy